Clinical trial

Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF)

NCT01467076

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2011-11-01

PhasePHASE2

Study timeline

Study start (unknown)2011-11-01Date precision: month

Registry last updated2019-04-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prematurityunresolved

Respiratory Insufficiencyunresolved

Pulmonary Hypertensionunresolved

Respiratory Distress Syndrome, Newbornunresolved

Interventions

Aerosolized Normal SalineDRUG

Inhaled PGE1DRUG

Sponsors & collaborators

NICHD Neonatal Research Networklead sponsor

National Center for Research Resources (NCRR)collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)collaborator

Mapped research locations

Los AngelesCalifornia, United States1 DallasTexas, United States1 BirminghamAlabama, United States1 ColumbusOhio, United States1 DurhamNorth Carolina, United States1 DetroitMichigan, United States1 RochesterNew York, United States1 AlbuquerqueNew Mexico, United States1 ProvidenceRhode Island, United States1 Iowa CityIowa, United States1 Palo AltoCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01467076 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.